Two years ago, we had a meeting with the head of the British National Formulary (BNF). The BNF is the booklet that is produced by the Royal Pharmaceutical Society and the Royal Society of Medicine and tells doctors how to treat particular diseases. At that meeting we were told that if we could produce evidence that the current guideline for treating Pernicious Anaemia (1mg injection every three months unless there’s neurological involvement) is not suitable for all patients then they would review the topic.
Yesterday we had a telephone interview with the Head of Content and we then presented them with our newly produced ‘Current Hydroxocobalamin Regimen for the Management of Pernicious Anaemia in the UK: A Review of the Evidence.’ Written by Dr Nicola Ward it is intended to show how the current guidelines are not suitable for all patients.
The conversation with the Head of Content was very promising but we were told that, because the BNF has now been accredited by NICE the process for changing the guidelines is thorough and consequently time-consuming. We were thanked for the Report (which is, as far as we know the first of its kind) and were assured that meetings would be held over the next three months. Hopefully we will have some positive news to report on this subject in the autumn.
Our thanks to Nicola for all her hard work in compiling the Review.